Accessibility Menu
Orthometrix logo

Orthometrix(OTC) OMRX

Market Cap$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1995)-100%
5 Year-100%
1 Year-99%
1 Month-99%
$0.00
+0.00%
+0.00Today
Orthometrix last closing stock price
MetricPriceDate
Last closeUSD 0.002026-01-28
Orthometrix stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-99%USD 0.002024-06-13
1 month-99%USD 0.002024-06-13
3 month-99%USD 0.002024-06-13
Year to date-99%USD 0.002024-06-13
1 year-99%USD 0.002024-06-13
3 year+0%USD 0.002023-01-09
5 year-99.97%USD 0.002021-01-14
Since inception-100%USD 9.331995-08-02

Orthometrix Financials at a Glance

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.46M

Net Income (TTM)

-$959.26K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-23.84 (Low)

Price

$0.00

Volume

530

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

OMRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Orthometrix

Orthometrix, Inc. is a specialized company focused on developing and distributing advanced technologies aimed at enhancing musculoskeletal mobility. Founded in 1993 and based in Naples, Florida, the company offers innovative solutions for pain management and rehabilitation.

Products and Services
  • Peripheral quantitative computed tomography (pQCT) systems for bone and muscle measurement
  • Patented motorized exercise systems with unique vibration technology for rehabilitation
  • Extracorporeal shock wave therapy (ESWT) systems for non-invasive pain treatment
Growth Outlook
  • Increasing demand for non-invasive pain management solutions in healthcare
  • Expansion into international markets to broaden customer base
  • Focus on partnerships with professional sports teams and fitness facilities
Financial Highlights
  • Recent quarterly revenue of 130,130, showing potential for growth
  • Trailing twelve months (TTM) gross profit margin of 69.6%, indicating strong profitability
  • Current ratio of 5.35, reflecting solid liquidity position
Orthometrix, Inc. operates in the medical specialties sector, providing a range of products that cater to healthcare, veterinary, and sports & fitness markets. The company has a history of innovation, with a focus on non-invasive technologies that address common musculoskeletal issues. The recent financial data indicates a potential for growth, particularly in light of the increasing demand for effective pain management solutions. The strong gross profit margin suggests that the company is well-positioned to capitalize on market opportunities. With a solid liquidity position, Orthometrix is equipped to navigate the evolving landscape of the healthcare industry.
AI Generated • Aug 1, 2026

Industry

Healthcare Equipment and Supplies

Headquarters

Naples, FL 34110, US

OMRX Financials

Key Financial Metrics (TTM)

Gross Margin

69.60%

Operating Margin

17.22%

Net Income Margin

27.20%

Return on Equity

-15.23%

Return on Capital

N/A

Return on Assets

51.39%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

53.21M

Volume

530

Avg. Volume

0

Financials (TTM)

Gross Profit

$591.06K

Operating Income

$551.70K

EBITDA

-$488.13K

Operating Cash Flow

-$572.60K

Capital Expenditure

$0.00

Free Cash Flow

-$572.60K

Cash & ST Invst.

$2.33K

Total Debt

$2.61M

Orthometrix Performance Analysis

Orthometrix sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42007-12-311.4%
Q12008-03-31-50.6%
Q22008-06-30-37.8%
Q32008-09-30-42.5%
Orthometrix sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42007-12-313.1%
Q12008-03-31-222.6%
Q22008-06-30N/A
Q32008-09-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2008YOY CHG

Revenue

$130.13K

-82.1%

Gross Profit

$12.59K

-96.3%

Gross Margin

9.68%

N/A

Market Cap

$100.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$14.29

N/A

Employees

7

N/A

Net Income

-$309.66K

-112.1%

EBITDA

-$189.45K

-155.8%

Quarterly Fundamentals

Name
Q3 2008YOY CHG

Total Cash

$2.33K

-75.6%

Total Debt

$2.61M

+30.7%

Accounts Receivable

$52.61K

-62.8%

Inventory

$473.84K

-31.9%

Long Term Debt

$6.57K

-82.8%

Short Term Debt

$2.60M

+32.9%

Return on Assets

51.39%

N/A

Return on Invested Capital

39.97%

N/A

Free Cash Flow

-$166.95K

-1161.2%

Operating Cash Flow

-$166.95K

-1111.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AXMPAXM Pharma, Inc.
$0.00+0.00%
IBXGiBX Group, Inc.
$0.00+0.00%
ARYXARYx Therapeutics, Inc.
$0.00+0.00%
HDVYHealth Discovery Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$108.96-0.13%
NVDANvidia
$221.65+0.05%
ONDSOndas
$8.88+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.76-0.04%

Questions About OMRX

What is the current price of Orthometrix?

Orthometrix is trading at $0.00 per share.

What is the 52-week range for Orthometrix?

Over the past 52 weeks, Orthometrix has traded between $0.00 and $0.00.

How much debt does Orthometrix have?

Orthometrix total debt is unavailable.

How much cash does Orthometrix have on hand?

Orthometrix does not have cash on hand data available.

What is Orthometrix’s dividend yield?

Orthometrix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.